×

Open WeChat and scan the QR code
Subscribe to our WeChat public account

HOME Overview Professional Field Industry Field Professionals Global Network News Publications Join Us Contact Us Subscribe 锦天城二十周年 CN EN JP
HOME > News > Transactions and Cases > AllBright Advises South Pharmaceutical on Listing on National Equities Exchange and Quotations

AllBright Advises South Pharmaceutical on Listing on National Equities Exchange and Quotations

 2014-10-292074

On October 21, 2014, Fujian South Pharmaceutical Co., Ltd. (FSP) (Stock code: 831207) was listed on the National Equities Exchange and Quotations with professional legal support from AllBright.


South Pharmaceutical is located in Mingxi County, Sanming City, Fujian Province. It is a high-tech company focused on the cultivation and commercialization of Taxus Wallichiana (Taxus yunnanensis) as well as other raw materials for fighting cancer. It is the main supplier worldwide for natural Paclitaxel, semi-synthesized Paclitaxel, Docetaxel, 10-DAB III (Taxus Baccata and Taxus Wallichiana). FSP is a main supplier for Gemcitabine, Irinotecan and the patented technologies for Docetaxel, Imatinib, and Erloitnib, etc. It aims to become a well-known oncology pharmaceutical company in the world in the next decade.


AllBright partner Shen Guoquan and associate Li Panfeng advised the client on the listing process.